Kiromic BioPharma, Inc. reports early efficacy results showing tumor stabilization in the third patient enrolled in the Companyโs Deltacel-01 Phase 1 clinical trial. Deltacel-01 is evaluating Deltacelโข (KB-GDT-01), Kiromicโs allogeneic....
Nested Therapeutics, a biotechnology company pioneering a next-generation precision medicine platform to address hard-to-treat cancers, today announced that the U.S. Food and Drug Administration (FDA) cleared the investigational new drug (IND)....
Akebia Therapeuticsยฎ, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that the U.S. Food and Drug Administration (FDA) has approved Vafseoยฎ (vadadustat)....
Viscient Biosciences ("Viscient") announced that its scientists, along with collaborators from University of California, San Diego, Sanford-Burnham-Prebys medical research institute, and Salk Institute, have published the first demonstration of a...
Octapharma USA has announced Balfaxarยฎ (prothrombin complex concentrate, human-lans; marketed in Europe and Canada as octaplexยฎ) is now available. The new non-activated four factor prothrombin complex concentrate (4F-PCC), approved by the U.S....